These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8894412)

  • 1. The use of intravenous immunoglobulins in the treatment of neuromuscular disorders.
    Voltz R; Hohlfeld R
    Curr Opin Neurol; 1996 Oct; 9(5):360-6. PubMed ID: 8894412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment of neuromuscular diseases.
    Kokontis L; Gutmann L
    Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders.
    van der Meché FG; van Doorn PA
    Muscle Nerve; 1997 Feb; 20(2):136-47. PubMed ID: 9040650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
    Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous gamma globulins in neuroimmunologic diseases.
    Latov N; Chaudhry V; Koski CL; Lisak RP; Apatoff BR; Hahn AF; Howard JF
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S126-32. PubMed ID: 11586280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines.
    Dalakas MC
    Muscle Nerve; 1999 Nov; 22(11):1479-97. PubMed ID: 10514226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease.
    Thornton CA; Griggs RC
    Ann Neurol; 1994 Mar; 35(3):260-8. PubMed ID: 8122878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin therapy for neuromuscular disorders.
    Ross MA
    Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases.
    Sala TP; Crave JC; Duracinsky M; Lepira Bompeka F; Tadmouri A; Chassany O; Cherin P
    Autoimmun Rev; 2018 Sep; 17(9):873-881. PubMed ID: 30005853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.
    Donofrio PD; Berger A; Brannagan TH; Bromberg MB; Howard JF; Latov N; Quick A; Tandan R
    Muscle Nerve; 2009 Nov; 40(5):890-900. PubMed ID: 19768755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular disorders: molecular and therapeutic insights.
    Mastaglia FL
    Lancet Neurol; 2005 Jan; 4(1):6-7. PubMed ID: 15620848
    [No Abstract]   [Full Text] [Related]  

  • 18. Lambert-Eaton syndrome.
    Anand A
    Hosp Pract (Off Ed); 1993 Mar; 28(3):12. PubMed ID: 8444979
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases.
    Gomperts ED; Darr F
    Neurology; 2002 May; 58(9):1444. PubMed ID: 12011310
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.